What are examples of aminoglycosides?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aminoglycoside Antibiotics: Examples and Classification

Core Aminoglycoside Agents

The primary aminoglycosides used in clinical practice include gentamicin, tobramycin, amikacin, streptomycin, kanamycin, and neomycin. 1, 2

Most Commonly Used Agents

  • Gentamicin is the most frequently prescribed aminoglycoside in clinical practice, particularly in neonatal units and for serious gram-negative infections 3, 2
  • Tobramycin is commonly used alongside gentamicin and amikacin for parenteral therapy of severe infections 4
  • Amikacin may be particularly effective against resistant organisms when other aminoglycosides fail 5, 6

Additional Aminoglycosides

  • Streptomycin has a distinct core ring structure that differs from all other aminoglycosides, explaining why cross-resistance between streptomycin and other aminoglycosides is uncommon 6
  • Kanamycin is used in specific clinical scenarios, particularly for drug-resistant tuberculosis 6
  • Neomycin is primarily used for bowel preparation rather than systemic infections 6

Structural and Pharmacologic Distinctions

Streptomycin stands apart structurally from other aminoglycosides, which has important resistance implications. 6

  • All E. faecium are intrinsically resistant to amikacin, kanamycin, netilmicin, and tobramycin 6
  • E. faecalis are often resistant to kanamycin and amikacin 6
  • Strains resistant to gentamicin may remain susceptible to streptomycin due to different resistance mechanisms 6

Clinical Context for Selection

For Plague Treatment

  • Streptomycin and gentamicin are both FDA-approved aminoglycosides for plague, with similar efficacy profiles 6

For Endocarditis

  • Gentamicin at 3 mg/kg per 24 hours IV/IM in 3 equally divided doses is standard for enterococcal endocarditis in combination with cell wall-active agents 6
  • Streptomycin at 15 mg/kg per 24 hours IV/IM in 2 equally divided doses is an alternative when gentamicin resistance is present 6

For Drug-Resistant Tuberculosis

  • Amikacin, kanamycin, streptomycin, and capreomycin (a cyclic polypeptide, not technically an aminoglycoside but grouped with "injectables") are used 6

For Urologic Procedures

  • Gentamicin 5 mg/kg IV single dose, tobramycin 5 mg/kg IV single dose, or amikacin 15 mg/kg IV single dose are options for prophylaxis 6

For Sepsis and Septic Shock

  • Gentamicin equivalent at 5-7 mg/kg daily is recommended for once-daily dosing in patients with preserved renal function 6

Critical Prescribing Considerations

All aminoglycosides share three key characteristics: concentration-dependent killing, a post-antibiotic effect, and synergism with other antibacterial drugs. 6

  • Aminoglycosides are polar drugs with poor gastrointestinal absorption, requiring intravenous or intramuscular administration 2
  • They are excreted renally and require dose adjustment in renal impairment 3
  • Single daily dosing is now preferred over traditional multiple daily dosing for most indications due to equal or better efficacy and reduced toxicity risk 1, 5

References

Guideline

Aminoglycoside Antibiotics: Clinical Applications and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What do I need to know about aminoglycoside antibiotics?

Archives of disease in childhood. Education and practice edition, 2017

Research

Aminoglycoside-induced nephrotoxicity.

Journal of pharmacy practice, 2014

Research

Aminoglycosides: a practical review.

American family physician, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.